Recent advances in polymeric microspheres for parenteral drug delivery – part 1

Bibliography

• Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm 2004;282(1-2):1-18
   PubMed Web of Science ®Google Scholar
• Tamber H, Johansen P, Merkle HP, Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 2005;57(3):357-76
   PubMed Web of Science ®Google Scholar
• Stovall K. Dissertation: Investigation of properties affecting controlled release of macromolecules from PLGA microspheres. University of Illinois at Urbana-Champaign; 2009.
   Google Scholar
• Ding AG, Schwendeman SP. Acidic microclimate pH distribution in PLGA microspheres monitored by confocal laser scanning microscopy. Pharm Res 2008;25(9):2041-52
   PubMed Web of Science ®Google Scholar
• Estey T, Kang J, Schwendeman SP, BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems. J Pharm Sci 2006;95(7):1626-39
   PubMed Web of Science ®Google Scholar
• Jiang W, Schwendeman SP. Stabilization of tetanus toxoid encapsulated in PLGA microspheres. Mol Pharm 2008;5(5):808-17
   PubMed Web of Science ®Google Scholar
• Mi FL, Shyu SS, Lin YM, Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein. Biomaterials 2003;24(27):5023-36
   PubMed Web of Science ®Google Scholar
• Sinha VR, Bansal K, Kaushik R, Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm 2004;278(1):1-23
   PubMed Web of Science ®Google Scholar
• Aslan S, Calandrelli L, Laurienzo P, Poly (D,L-lactic acid)/poly (-caprolactone) blend membranes: preparation and morphological characterisation. J Mater Res 2000;35(7):1615-22
   Google Scholar
• Mundargi RC, Srirangarajan S, Agnihotri SA, Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. J Control Release 2007;119(1):59-68
   PubMed Web of Science ®Google Scholar
• Dash TK, Konkimalla VB. Poly-(caprolactone) based formulations for drug delivery and tissue engineering: a review. J Control Release 2012;158(1):15-33
   PubMed Web of Science ®Google Scholar
• Jain JP, Modi S, Domb AJ, Role of polyanhydrides as localized drug carriers. J Control Release 2005;103(3):541-63
   PubMed Web of Science ®Google Scholar
• Kumar N, Langer RS, Domb AJ. Polyanhydrides: an overview. Adv Drug Deliv Rev 2002;54(7):889-910
   PubMed Web of Science ®Google Scholar
• Katti DS, Lakshmi S, Langer R, Toxicity, biodegradation and elimination of polyanhydrides. Adv Drug Deliv Rev 2002;54(7):933-61
   PubMed Web of Science ®Google Scholar
• Gunatillake P, Mayadunne R, Adhikari R. Recent developments in biodegradable synthetic polymers. Biotechnol Annu Rev 2006;12:301-47
   PubMedGoogle Scholar
• Peng D, Huang K, Liu Y, Preparation of novel polymeric microspheres for controlled release of finasteride. Int J Pharm 2007;342(1-2):82-6
   PubMed Web of Science ®Google Scholar
• Hu B, Tu YY, Yan GP, Polycarbonate microspheres containing mitomycin C and magnetic powders as potential hepatic carcinoma therapeutics. Colloids Surf B Biointerfaces 2011;84(2):550-5
   PubMed Web of Science ®Google Scholar
• Joseph NJ, Lakshmi S, Jayakrishnan A. A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits. J Control Release 2002;79(1-3):71-9
   PubMed Web of Science ®Google Scholar
• Heller J, Barr J, Ng SY, Poly(ortho esters): synthesis, characterization, properties and uses. Adv Drug Deliv Rev 2002;54(7):1015-39
   PubMed Web of Science ®Google Scholar
• Chiellini F, Piras AM, Errico C, Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications. Nanomedicine (Lond) 2008;3(3):367-93
   PubMed Web of Science ®Google Scholar
• Deng JS, Li L, Tian Y, In vitro characterization of polyorthoester microparticles containing bupivacaine. Pharm Dev Technol 2003;8(1):31-8
   PubMed Web of Science ®Google Scholar
• Wang C, Ge Q, Ting D, Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater 2004;3(3):190-6
   PubMed Web of Science ®Google Scholar
• Wang S, Wan AC, Xu X, A new nerve guide conduit material composed of a biodegradable poly(phosphoester). Biomaterials 2001;22(10):1157-69
   PubMed Web of Science ®Google Scholar
• Lakshmi S, Katti DS, Laurencin CT. Biodegradable polyphosphazenes for drug delivery applications. Adv Drug Deliv Rev 2003;55(4):467-82
   PubMed Web of Science ®Google Scholar
• Zhao Z, Wang J, Mao HQ, Polyphosphoesters in drug and gene delivery. Adv Drug Deliv Rev 2003;55(4):483-99
   PubMed Web of Science ®Google Scholar
• Xu X, Yee WC, Hwang PY, Peripheral nerve regeneration with sustained release of poly(phosphoester) microencapsulated nerve growth factor within nerve guide conduits. Biomaterials 2003;24(13):2405-12
   PubMed Web of Science ®Google Scholar
• Shishatskaya EI, Voinova ON, Goreva AV, Biocompatibility of polyhydroxybutyrate microspheres: in vitro and in vivo evaluation. J Mater Sci Mater Med 2008;19(6):2493-502
   PubMed Web of Science ®Google Scholar
• Salman MA, Sahin A, Onur MA, Tramadol encapsulated into polyhydroxybutyrate microspheres: in vitro release and epidural analgesic effect in rats. Acta Anaesthesiol Scand 2003;47(8):1006-12
   PubMed Web of Science ®Google Scholar
• Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 2010;62(1):12-27
   PubMed Web of Science ®Google Scholar
• Sinha VR, Singla AK, Wadhawan S, Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004;274(1-2):1-33
   PubMed Web of Science ®Google Scholar
• Guerrero S, Teijón C, Muñiz E, Characterization and in vivo evaluation of ketotifen-loaded chitosan microspheres. Carbohydr Polym 2010;79(4):1006-13
   Web of Science ®Google Scholar
• Hejazi R, Amiji M. Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres. Int J Pharm 2002;235(1-2):87-94
   PubMed Web of Science ®Google Scholar
• George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan–a review. J Control Release 2006;114(1):1-14
   PubMed Web of Science ®Google Scholar
• Hori Y, Winans AM, Irvine DJ. Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors. Acta Biomater 2009;5(4):969-82
   PubMed Web of Science ®Google Scholar
• Matricardi P, Meo CD, Coviello T, Recent advances and perspectives on coated alginate microspheres for modified drug delivery. Expert Opin Drug Deliv 2008;5(4):417-25
   PubMed Web of Science ®Google Scholar
• Tafaghodi M, Sajadi Tabassi SA, Jaafari MR. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN. Int J Pharm 2006;319(1-2):37-43
   PubMed Web of Science ®Google Scholar
• Liao YH, Jones SA, Forbes B, Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv 2005;12(6):327-42
   PubMed Web of Science ®Google Scholar
• Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev 2011;91(1):221-64
   PubMed Web of Science ®Google Scholar
• Yun YH, Goetz DJ, Yellen P, Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 2004;25(1):147-57
   PubMed Web of Science ®Google Scholar
• Chung HJ, Jung JS, Park TG. Fabrication of adipose-derived mesenchymal stem cell aggregates using biodegradable porous microspheres for injectable adipose tissue regeneration. J Biomater Sci Polym Ed 2010
   Web of Science ®Google Scholar
• Nitta N, Ohta S, Tanaka T, Gelatin microspheres: initial clinical experience for the transcatheter arterial embolization. Eur J Radiol 2008;67(3):536-40
   PubMed Web of Science ®Google Scholar
• Jin YC, Kim SW, Cheng F, The effect of biodegradable gelatin microspheres on the neuroprotective effects of high mobility group box 1 A box in the postischemic brain. Biomaterials 2011;32(3):899-908
   PubMed Web of Science ®Google Scholar
• Karim AA, Bhat R. Gelatin alternatives for the food industry: recent developments, challenges and prospects. Trends Food Sci Tech 2008;19(12):644-56
   Web of Science ®Google Scholar
• Shiba H, Okamoto T, Futagawa Y, Adenovirus vector-mediated gene transfer using degradable starch microspheres for hepatocellular carcinoma in rats. J Surg Res 2006;133(2):193-6
   PubMed Web of Science ®Google Scholar
• Selek H, Sahin S, Kas HS, Formulation and characterization of formaldehyde cross-linked degradable starch microspheres containing terbutaline sulfate. Drug Dev Ind Pharm 2007;33(2):147-54
   PubMed Web of Science ®Google Scholar
• Morise Z, Sugioka A, Kato R, Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases. J Gastrointest Surg 2006;10(2):249-58
   PubMed Web of Science ®Google Scholar
• Diwan M, Khar RK, Talwar GP. Tetanus toxoid loaded 'preformed microspheres' of cross-linked dextran. Vaccine 2001;19(28-29):3853-9
   PubMed Web of Science ®Google Scholar
• Liu Z, Ballinger JR, Rauth AM, Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres. J Pharm Pharmacol 2003;55(8):1063-73
   PubMed Web of Science ®Google Scholar
• Vlugt-Wensink KD, de Vrueh R, Gresnigt MG, Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation. Pharm Res 2007;24(12):2239-48
   PubMed Web of Science ®Google Scholar
• Stenekes RJ, Loebis AE, Fernandes CM, Degradable dextran microspheres for the controlled release of liposomes. Int J Pharm 2001;214(1-2):17-20
   PubMed Web of Science ®Google Scholar
• Mao S, Xu J, Cai C, Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm 2007;334(1-2):137-48
   PubMed Web of Science ®Google Scholar
• Feng L, Qi XR, Zhou XJ, Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. J Control Release 2006;112(1):35-42
   PubMed Web of Science ®Google Scholar
• Alexis F. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Polym Int 2005;54(1):36-46
   Web of Science ®Google Scholar
• Chakravarthi SS, Robinson DH. Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles. Int J Pharm 2011;409(1-2):111-20
   PubMed Web of Science ®Google Scholar
• Meng ZX, Zheng W, Li L, Fabrication, characterization and in vitro drug release behavior of electrospun PLGA/chitosan nanofibrous scaffold. Mater Chem Phys 2011;125(3):606-11
   Web of Science ®Google Scholar
• Ruan G, Feng SS, Li QT. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. J Control Release 2002;84(3):151-60
   PubMed Web of Science ®Google Scholar
• Hamishehkar H, Emami J, Najafabadi AR, The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Colloids Surf B Biointerfaces 2009;74(1):340-9
   PubMed Web of Science ®Google Scholar
• Wang X, Xu H, Zhao Y, Poly(lactide-co-glycolide) encapsulated hydroxyapatite microspheres for sustained release of doxycycline. Mater Sci Eng B 2012;177(4):367-72
   Web of Science ®Google Scholar
• Garbayo E, Ansorena E, Lanciego JL, Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres. Eur J Pharm Biopharm 2008;69(3):844-51
   PubMed Web of Science ®Google Scholar
• Chu DF, Fu XQ, Liu WH, Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Int J Pharm 2006;325(1-2):116-23
   PubMed Web of Science ®Google Scholar
• Mao S, Shi Y, Li L, Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Eur J Pharm Biopharm 2008;68(2):214-23
   PubMed Web of Science ®Google Scholar
• Jeong YI, Song JG, Kang SS, Preparation of poly(DL-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid. Int J Pharm 2003;259(1-2):79-91
   PubMed Web of Science ®Google Scholar
• Choi HS, Seo SA, Khang G, Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles. Int J Pharm 2002;234(1-2):195-203
   PubMed Web of Science ®Google Scholar
• Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001;22(3):231-41
   PubMed Web of Science ®Google Scholar
• Frauke Pistel K, Breitenbach A, Zange-Volland R, Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid). J Control Release 2001;73(1):7-20
   PubMed Web of Science ®Google Scholar
• Sandor M, Enscore D, Weston P, Effect of protein molecular weight on release from micron-sized PLGA microspheres. J Control Release 2001;76(3):297-311
   PubMed Web of Science ®Google Scholar
• Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release 2005;102(2):313-32
   PubMed Web of Science ®Google Scholar
• Ruan G, Ng JK, Feng SS. Effects of polymer, organic solvent and mixing strength on integrity of proteins and liposomes encapsulated in polymeric microspheres fabricated by the double emulsion process. J Microencapsul 2004;21(4):399-412
   PubMed Web of Science ®Google Scholar
• Vandervoort J, Ludwig A. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. Int J Pharm 2002;238(1-2):77-92
   PubMed Web of Science ®Google Scholar
• Sturesson C, Degling Wikingsson L. Comparison of poly(acryl starch) and poly(lactide-co-glycolide) microspheres as drug delivery system for a rotavirus vaccine. J Control Release 2000;68(3):441-50
   PubMed Web of Science ®Google Scholar
• Pradeesh TS, Sunny MC, Varma HK, Preparation of microstructured hydroxyapatite microspheres using oil in water emulsions. Bull Mater Sci 2005;28(5):383-90
   Web of Science ®Google Scholar
• Zhou YX, Li SL, Fu HL, Fabrication and in vitro drug release study of microsphere drug delivery systems based on amphiphilic poly-alpha,beta-[N-(2-hydroxyethyl)-L-aspartamide]-g-poly(L-lactide) graft copolymers. Colloids Surf B Biointerfaces 2008;61(2):164-9
   PubMed Web of Science ®Google Scholar
• Street TO, Bolen DW, Rose GD. A molecular mechanism for osmolyte-induced protein stability. Proc Natl Acad Sci USA 2006;103(38):13997-4002
   PubMed Web of Science ®Google Scholar
• Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm 2008;363(1-2):26-39
   PubMed Web of Science ®Google Scholar
• Yang Y-Y, Chung T-S, Bai X-L, Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chem Eng Sci 2000;55(12):2223-36
   Web of Science ®Google Scholar
• Pistel KF, Kissel T. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique. J Microencapsul 2000;17(4):467-83
   PubMed Web of Science ®Google Scholar
• Martinez-Sancho C, Herrero-Vanrell R, Negro S. Optimisation of aciclovir poly(D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study. Int J Pharm 2004;273(1-2):45-56
   PubMed Web of Science ®Google Scholar
• Cai C, Mao S, Germershaus O, Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA. J Microencapsul 2009;26(4):334-45
   PubMed Web of Science ®Google Scholar
• Kim TK, Yoon JJ, Lee DS, Gas foamed open porous biodegradable polymeric microspheres. Biomaterials 2006;27(2):152-9
   PubMed Web of Science ®Google Scholar
• Kim HK, Chung HJ, Park TG. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone. J Control Release 2006;112(2):167-74
   PubMed Web of Science ®Google Scholar
• Wang J, Wang BM, Schwendeman SP. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres. Biomaterials 2004;25(10):1919-27
   PubMed Web of Science ®Google Scholar
• He J, Feng M, Zhou X, Stabilization and encapsulation of recombinant human erythropoietin into PLGA. Int J Pharm 2011;416(1):69-76
   PubMed Web of Science ®Google Scholar
• Stivaktakis N, Nikou K, Panagi Z, PLA and PLGA microspheres of beta-galactosidase: effect of formulation factors on protein antigenicity and immunogenicity. J Biomed Mater Res A 2004;70(1):139-48
   PubMed Web of Science ®Google Scholar
• Sah H. Ethyl formate - alternative dispersed solvent useful in preparing PLGA microspheres. Int J Pharm 2000;195(1-2):103-13
   PubMed Web of Science ®Google Scholar
• Yang Q, Owusu-Ababio G. Biodegradable progesterone microsphere delivery system for osteoporosis therapy. Drug Dev Ind Pharm 2000;26(1):61-70
   PubMed Web of Science ®Google Scholar
• Blanco-Prieto M, Lecaroz C, Renedo M, In vitro evaluation of gentamicin released from microparticles. Int J Pharm 2002;242(1-2):203-6
   PubMed Web of Science ®Google Scholar
• Barrow WW. Microsphere technology for chemotherapy of mycobacterial infections. Curr Pharm Des 2004;10(26):3275-84
   PubMed Web of Science ®Google Scholar
• Nijsen JF, van het Schip AD, Hennink WE, Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours. Curr Med Chem 2002;9(1):73-82
   PubMed Web of Science ®Google Scholar
• Liggins RT, Cruz T, Min W, Intra-articular treatment of arthritis with microsphere formulations of paclitaxel: biocompatibility and efficacy determinations in rabbits. Inflamm Res 2004;53(8):363-72
   PubMed Web of Science ®Google Scholar
• Reynolds RA, Stramski D, Wright VM, Measurements and characterization of particle size distributions in coastal waters. J Geophys Res 2010;115(C8):C08024
   Web of Science ®Google Scholar
• Burgess DJ, Duffy E, Etzler F, Particle size analysis: AAPS workshop report, cosponsored by the food and drug administration and the United States Pharmacopeia. AAPS J 2004;6(3):e20
   PubMed Web of Science ®Google Scholar
• Coccoli V, Luciani A, Orsi S, Engineering of poly(epsilon-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic. J Mater Sci Mater Med 2008;19(4):1703-11
   PubMed Web of Science ®Google Scholar
• Abdel-Fattah WI, Jiang T, El-Bassyouni Gel T, Synthesis, characterization of chitosans and fabrication of sintered chitosan microsphere matrices for bone tissue engineering. Acta Biomater 2007;3(4):503-14
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Schafer U, Lehr CM. Structural analysis of microparticles by confocal laser scanning microscopy. AAPS PharmSciTech 2000;1(3):E17
   PubMedGoogle Scholar
• van de Weert M, van 't Hof R, van der Weerd J, Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. J Control Release 2000;68(1):31-40
   PubMed Web of Science ®Google Scholar
• Kim TH, Park TG. Critical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheres. Int J Pharm 2004;271(1-2):207-14
   PubMed Web of Science ®Google Scholar
• Ruan G, Feng SS. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 2003;24(27):5037-44
   PubMed Web of Science ®Google Scholar
• Li LC, Tian Y. Zeta potential. In: Swarbrick J, editors. Encyclopedia of pharmaceutical technology. 3rd edition. 2007; Volume 6 Set Informa Health USA Inc., 270 Madison Avenue, New York, NY 10016, p. 4117-28
   Google Scholar
• Martinez-Sancho C, Herrero-Vanrell R, Negro S. Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administration. J Control Release 2004;99(1):41-52
   PubMed Web of Science ®Google Scholar
• Gupte A, Ciftci K. Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres. Int J Pharm 2004;276(1-2):93-106
   PubMed Web of Science ®Google Scholar
• Wang L, Chaw CS, Yang YY, Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying. Biomaterials 2004;25(16):3275-82
   PubMed Web of Science ®Google Scholar
• Sipos P, Szabó A, Erős I, A DSC and Raman spectroscopic study of microspheres preparedwith polar cosolvents by different techniques. J Therm Anal Calorim 2008;94(1):109-18
   Web of Science ®Google Scholar
• Sipos P, Szűcs M, Szabó A, An assessment of the interactions between diclofenac sodium and ammonio methacrylate copolymer using thermal analysis and Raman spectroscopy. J Pharm Biomed Anal 2008;46(2):288-94
   PubMed Web of Science ®Google Scholar
• Kumar R, Palmieri MJ Jr. Points to consider when establishing drug product specifications for parenteral microspheres. AAPS J 2010;12(1):27-32
   PubMed Web of Science ®Google Scholar
• Blanco-Prieto MJ, Campanero MA, Besseghir K, Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. J Control Release 2004;96(3):437-48
   PubMed Web of Science ®Google Scholar
• Kim TH, Jiang HH, Park CW, PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity. J Control Release 2011;150(1):63-9
   PubMed Web of Science ®Google Scholar
• Li Z, Li L, Liu Y, Development of interferon alpha-2b microspheres with constant release. Int J Pharm 2011;410(1-2):48-53
   PubMed Web of Science ®Google Scholar
• Zolnik BS, Burgess DJ. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Control Release 2008;127(2):137-45
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang J, Zhang X, Synchronic release of two hormonal contraceptives for about one month from the PLGA microspheres: in vitro and in vivo studies. J Control Release 2008;129(3):192-9
   PubMed Web of Science ®Google Scholar